Stock listing

Fulgent Genetics, Inc.

Selected listing: 7F0 · MUN · EUR · DE

Fulgent Genetics, Inc. (Munich:7F0), Health Services. Latest release Jul 30, 2026: Fulgent Reports Second Quarter 2026 Financial Results.

7F0:MUNEURDEUpdated October 2, 2026

Ticker: Munich:7F0
Asset type: Stock
Sector: Health Services
Industry: Medical/Nursing Services
Exchange: Munich
Currency: EUR

About Fulgent Genetics, Inc.

The company specializes in genetic testing and related services, providing innovative solutions for healthcare providers and patients. Fulgent Genetics aims to enhance the understanding of genetic conditions through its advanced testing technologies.

Latest news from Fulgent Genetics, Inc.

Fulgent Reports Second Quarter 2026 Financial Results

July 29, 2026

Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

July 9, 2026

Flagship Pioneering Announces Formation of Terion, a Company Delivering the Digital Infrastructure to Power Modern Agriculture

June 18, 2026

Fulgent Presents Updated FID-007 Data at ASCO 2026

June 1, 2026

Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting

May 21, 2026

All Fulgent Genetics, Inc. news →

Events

Replays

Fulgent Genetics, Inc. (FLGT) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 04:30 PM ET
Watch
Fulgent Genetics, Inc. (FLGT) Q1 2026 Earnings Call
Fri, May 01, 2026 · 08:30 AM ET
Watch
Fulgent Genetics, Inc. (FLGT) Q4 2025 Earnings Call
Fri, Feb 27, 2026 · 08:30 AM ET
Watch

Research Fulgent Genetics, Inc.

Fulgent Genetics, Inc. company profile

View the public company page for Fulgent Genetics, Inc. on 6ix.

Fulgent Genetics, Inc. news

Read company news and market updates connected to Fulgent Genetics, Inc..

Fulgent Genetics, Inc. investor events

Find investor webinars, events, and replay context for Fulgent Genetics, Inc..